This exceptional safety profile was consistent across multiple dose levels, administration routes, and treatment durations
Yet a single milligram value can serve different goals: 1.0 mg is a modest weight-loss dose but the proven kidney dose in type 2 diabetes
Licensed professionals are authorized to administer BPC-157 in a monitored, documented human context
Protocol Quick-Reference PRECLINICAL ONLY: NNMT inhibition research compound Dosing Amount No established human dose (mouse: ~34 mg/kg/day SC) Frequency No established human frequency Duration No established human duration Administration Route Oral Schedule N/A (preclinical compound) Timing NO HUMAN DOSING DATA EXISTS
Symptoms include fatigue, pale skin, headaches, and mood changes
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial